Aromasin (exemestane)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
WARNINGS AND PRECAUTIONS
2 subsections added:
Use in Premenopausal Women
AROMASIN is not indicated for the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts